The FLUTE project will advance and scale up data-driven healthcare by developing novel methods for privacy-preserving cross-border utilization of data hubs. Advanced research will be performed to push the performance envelope of secure multi-party computation in Federated Learning, including the associated AI models and secure execution environments. 

The technical innovations will be integrated in a privacy-enforcing platform that will provide innovators with a provenly secure environment for federated healthcare AI solution development, testing and deployment, including the integration of real-world health data from the data hubs and the generation and utilization of synthetic data. 

To maximize the impact, adoption and replicability of the results, the project will contribute to the global HL7 FHIR standard development and create novel guidelines for GDPR-compliant cross-border Federated Learning in healthcare. 

To demonstrate the practical use and impact of the results, the project will integrate the FLUTE platform with health data hubs located in three different countries, use their data to develop a novel federated AI toolset for diagnosis of clinically significant prostate cancer and perform a multi-national clinical validation of its efficacy, which will help to improve predictions of aggressive prostate cancer while avoiding unnecessary biopsies, thus improving the welfare of patients and significantly reducing the associated costs. 

The 11- strong consortium will include three clinical (data) partners from three different countries, three technology SMEs, three technology research partners, a legal & ethics partner and a standards organization. 

The FLUTE project will boost the competitiveness of European SMEs and research organizations in the digital age, and increase the productivity and efficiency of the healthcare industry.

Our role

Timelex is acting as a legal and ethics partner to the FLUTE consortium, handling all legal and ethical issues related to the project, including GDPR and privacy protection, supporting validation studies from the legal perspective, and helping to mitigate other regulatory and ethical challenges related to the use of FL.